Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

Thursday’s trading has closed, but GSK is being traded in the after-hours session. After-Hours quote »
43.59
Delayed Data
As of 4:01pm ET
 +0.97 / +2.28%
Today’s Change
41.19
Today|||52-Week Range
49.24
+1.99%
Year-to-Date

Today’s Trading

Previous close42.62
Today’s open43.27
Day’s range43.10 - 43.65
Volume7,694,064
Average volume (3 months)4,054,192
Market cap$103.7B
Dividend yield5.81%
Data as of 4:01pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)-46.46%
Earnings growth (this year)-19.66%
Earnings growth (next 5 years)+5.60%
Revenue growth (last year)-8.75%
P/E ratio10.4
Price/Sales2.74
Price/Book15.59

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-0.26-0.20%
BMYBristol-Myers Squibb-0.43-0.66%
ABBVAbbVie-0.61-0.86%
LLYEli Lilly and Co-0.55-0.65%
Data as of 4:02pm ET, 07/30/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)$0.64
Annual revenue (last year)$37.9B
Annual profit (last year)$4.5B
Net profit margin11.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts